The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

NCT05555901 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Fruquintinib+ chemotherapy
DRUG: Bevacizumab+ chemotherapy

Sponsor

Fudan University